abstract |
An anti-Ang-2 antibody that specifically binds angiopoietin-2 (Ang-2), a neovascularization-inducing factor, a hybridoma cell line that produces a monoclonal antibody of the anti-Ang- There is provided a pharmaceutical composition comprising said anti-Ang-2 antibody as an active ingredient. |